Does burning fat make tumor immune hot? Discovery of CD47 overexpression by radiation induced fatty acid oxidation

Nian Jiang; Bowen Xie; Ming Fan; Jian Jian Li

doi:10.1016/j.gendis.2022.07.019

您当前的位置：

首页 >

文章列表页 >

Does burning fat make tumor immune hot? Discovery of CD47 overexpression by radiation induced fatty acid oxidation

Full-length article | 更新时间：2023-08-29

- Does burning fat make tumor immune hot? Discovery of CD47 overexpression by radiation induced fatty acid oxidation
- Does burning fat make tumor immune hot? Discovery of CD47 overexpression by radiation induced fatty acid oxidation
- Genes & Diseases 2023年10卷第1期
- 作者机构：
  
  1. Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento,CA,USA,95817
  2. Department of Neurosurgery, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University,Hunan,Changsha,China,410008
  3. Institute for Immunology and School of Medicine, Tsinghua University,Beijing,China,100084
  4. NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento,CA,USA,95817
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2022.07.019
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-1-1，
扫描看全文
Nian Jiang, Bowen Xie, Ming Fan, 等. Does burning fat make tumor immune hot? Discovery of CD47 overexpression by radiation induced fatty acid oxidation[J]. Genes & Diseases, 2023,10(1).

Nian Jiang, Bowen Xie, Ming Fan, et al. Does burning fat make tumor immune hot? Discovery of CD47 overexpression by radiation induced fatty acid oxidation[J]. Genes & Diseases, 2023,10(1).
Nian Jiang, Bowen Xie, Ming Fan, 等. Does burning fat make tumor immune hot? Discovery of CD47 overexpression by radiation induced fatty acid oxidation[J]. Genes & Diseases, 2023,10(1). DOI： 10.1016/j.gendis.2022.07.019.

Nian Jiang, Bowen Xie, Ming Fan, et al. Does burning fat make tumor immune hot? Discovery of CD47 overexpression by radiation induced fatty acid oxidation[J]. Genes & Diseases, 2023,10(1). DOI： 10.1016/j.gendis.2022.07.019.

摘要

Abstract

lthough extensively studied

it is unknown what is the major cellular energy driving tumor metastasis after anti-cancer radiotherapy. Metabolic reprogramming is one of the fundamental hallmarks in carcinogenesis and tumor progression featured with the increased glycolysis in solid tumors. However

accumulating evidence indicates that in addition to the rudimentary glycolytic pathway

tumor cells are capable of reactivating mitochondrial OXPHOS under genotoxic stress condition to meet the increasing cellular fuel demand for repairing and surviving anti-cancer radiation. Such dynamic metabolic rewiring may play a key role in cancer therapy resistance and metastasis. Interestingly

data from our group and others have demonstrated that cancer cells can re-activate mitochondrial oxidative respiration to boost an annexing energy to meet the increasing cellular fuel demand for tumor cells surviving genotoxic anti-cancer therapy with metastatic potential.

关键词

Keywords

CD47Immune checkpointImmunotherapyMetabolic rewiringRadiation therapyTumor acquired resistance

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma

Cancer organoids: A platform in basic and translational research

Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration

Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy

The link between intracellular calcium signaling and exosomal PD-L1 in cancer progression and immunotherapy